Pelvic Inflammatory Disease: Clinical Trials

3 unknown. 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	3	Unknown 3

Follow Pelvic Inflammatory Disease: new trials by email Literature Review of Pelvic Inflammatory Disease trials Research Report on Pelvic Inflammatory Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries Azithromycin 500 mg, Mefoxin 2g - Endometritis, Cesarean Section; Infection	Phase 2	Unknown	RWJ Barnabas Health at Jersey City Medical Center	800	2019-09-15	2019-09-17
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae Comprehensive treatment of TCM, Expectant treatment - Pelvic Inflammatory Disease	Phase 2	Unknown	Shanghai University of Traditional Chinese Medicine	175	2016-11-01	2016-11-23
The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section ceftriaxone - Endometritis	Phase 2	Unknown	Cairo University	600	2016-04-01	2016-04-19

Narrower conditions

Endometritis (2)  ·  Infections (1)  ·  Wound Infection (1)

Broader conditions

Adnexal Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Urogenital Diseases (3)  ·  Uterine Diseases (2)  ·  Infections (1)  ·  Pelvic Infection (1)

Interventions

Azithromycin (1)  ·  Cefoxitin (1)  ·  Ceftriaxone (1)  ·  Oral Medicine (1)

Sponsors

Cairo University (1)  ·  RWJ Barnabas Health at Jersey City Medical Center (1)  ·  Shanghai University of Traditional Chinese Medicine (1)

Countries

China (1)  ·  United States (1)

Top investigators

Moutaz Elsherbini, MD (1)  ·  Tali Wajsfeld, MD (1)